Phase 1 Clinical Trial Timelines Significantly Accelerated Top-Line Data Readout from Single Ascending Dose Part 1 Now Expected in the Third Quarter of 2024 First Patient Dosed in the Multiple Ascending Dose Part 2 Expected in the ...
CAMBRIDGE, Mass. , March 8, 2024 /PRNewswire/ -- Regor Therapeutics Group ("Regor"), a clinical-stage global biopharmaceutical company powered by a cutting-edge drug discovery engine and differentiated clinical development pipeline, today ...
WASHINGTON , March 1, 2024 /PRNewswire/ -- To kick off Obesity Care Week 2024, more than 60 advocates with the Obesity Action Coalition (OAC) will gather on Capitol Hill to meet with more than 70 legislators to express the importance of ...
First Patient Expected to be Randomized in the Second Quarter of 2024 CAMBRIDGE, Mass. , Feb. 29, 2024 /PRNewswire/ --Â NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on ...
Preclinical Studies Show DA-1726 Elicits Superior Weight Loss Compared to Semaglutide (Wegovy™) and Similar Weight Loss Compared to Tirzepatide (Mounjaro™), While Consuming More Food Initiation of Phase 1 Clinical Trial Expected to Occur ...
CAMBRIDGE, Mass. , Dec. 28, 2023 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that it has submitted an ...
TAMPA, Fla. , Nov. 28, 2023 /PRNewswire/ -- The Obesity Action Coalition (OAC) announces the publication of a "Joint Statement in Support of Closing Gaps in the Drug Approval Process and Drug Labeling for People with Obesity." The ...
With over 100 million US adults experiencing obesity, and the condition accounting for $173 billion dollars in extra health costs annually, health tech company Theator set out to examine how bariatric surgeries are stacking up, only to find ...
Mazdutide demonstrates its differentiated advantages as a novel dual agonist of GLP-1 and GCG receptor with superior weight loss efficacy, significant improvement in a series of cardiometabolic indicators (waist circumferenc e, ...
WASHINGTON , Oct. 10, 2023 /PRNewswire/ -- Live-stream and In Person Event, October 11 , 2:00 – 4:00 PM, ET National Press Club, Washington DC , or live stream – register here: The State of Obesity: Creating Pathways to a ...
Individuals with larger fat cells are more likely to experience weight loss over time, while those with smaller fat cells tend to gain weight , suggesting a potential predictive factor for weight gain based on fat cell size, as per a study presented ...
Surveying adults with obesity about their childhood weight perception could predict mortality risk, with a UK Biobank study revealing higher mortality rates for those who were slim...
Mayo Clinic’s latest study demonstrates that laparoscopic sleeve gastrectomy accelerates weight reduction, diminishes obesity-linked health complications, and enhances the possibility of kidney transplant qualification for individuals with severe ...
Nerve-stimulation treatment for obstructive sleep apnea is now accessible to severely obese patients with BMIs up to 40, marking a significant expansion beyond the conventional healthy BMI range of 18.5 to 24.9. ...
Childhood obesity not only doubles but more than doubles the risk of future multiple sclerosis —a chilling revelation underscoring the urgent need for proactive measures to combat this alarming health trajectory. The study is by Professor Claude ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers